Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

The Larry King Cardiac Foundation Fundraising Gala Underwritten by St. Jude Medical, Inc.; Support Allows for Complete Patient Care to Save a Heart a Day.


WASHINGTON -- The Larry King Cardiac Foundation (LKCF LKCF Larry King Cardiac Foundation ) proudly announces an underwriting donation from St. Jude Medical St. Jude Medical, Inc. NYSE: STJ is a $2.9 billion global cardiovascular device company, with headquarters in St. Paul, Minnesota, United States. The company sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide. , Inc. (NYSE NYSE

See: New York Stock Exchange
:STJ STJ Superior Tribunal de Justica (Brazil)
STJ Supremo Tribunal de Justiça (Portugal)
STJ Superconducting Tunnel Junction
STJ San Giljan (postal locality, Malta) 
) which will offer complete support of the Washington, DC fundraising gala, An Evening with Larry King and Friends on March 24, 2006. It will be held at The Ritz-Carlton, Washington, DC.

The funds provided by St. Jude Medical will actively support the ambitious mission of LKCF to Save a Heart a Day by allowing all proceeds raised through the gala to be directed completely to life-saving patient treatment. As part of its sponsorship, St. Jude Medical will also donate cardiovascular medical devices through LKCF to support patients who cannot afford adequate medical care.

"The Larry King Cardiac Foundation is honored to welcome St. Jude Medical to the Foundation family," says Larry King, Jr., president of LKCF. "Heart disease takes the lives of 500,000 men and women annually in the United States. This funding from St. Jude Medical is monumental in helping us save a heart a day."

"We are proud to work with The Larry King Cardiac Foundation to provide life-saving cardiovascular devices and therapies for patients in need," said Daniel J. Starks, Chairman, President and Chief Executive Officer of St. Jude Medical, Inc. "The Foundation's programs are consistent with St. Jude Medical's mission to make life better through excellence in medical technology and services."

St. Jude Medical's product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT (1) (C RunTime) See runtime library.

(2) (Cathode Ray Tube) A vacuum tube used as a display screen in a computer monitor or TV. The viewing end of the tube is coated with phosphors, which emit light when struck by electrons.
) devices, pacemakers, electrophysiology catheters, vascular closure devices, heart valve replacement Heart Valve Replacement Definition

Heart valve replacement is a surgical procedure during which surgeons remove a damaged valve from the heart and substitute a healthy one.
 and repair products, and neurostimulation devices.

About Larry King Cardiac Foundation

LKCF provides funding for life-saving treatment for individuals who, due to limited means or inadequate insurance, would otherwise be unable to receive vital cardiac treatment. The Foundation works in conjunction with major medical centers throughout the nation to ensure that such patients receive life-saving medical attention. For more information, please visit www.lkcf.org.

About St. Jude Medical

St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include: cardiac rhythm management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. , atrial fibrillation atrial fibrillation

Irregular rhythm (arrhythmia) of contraction of the atria (upper heart chambers). The most common major arrhythmia, it may result as a consequence of increased fibrous tissue in the aging heart, of heart disease, or in association with severe infection.
, cardiac surgery, cardiology, and neuromodulation. Headquartered in St. Paul, Minnesota, the Company employs approximately 10,000 people worldwide. For more information, please visit www.sjm.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 16, 2006
Words:383
Previous Article:Audible Announces 2005 Financial Results; Company Reports 2005 Revenue of $63.0 Million; 2005 Diluted EPS of $(0.02); Announces Share Buyback Program.
Next Article:GTSI Announces Executive Officer Changes; James Leto to Join GTSI as President and Chief Executive Officer.
Topics:



Related Articles
St. Jude Medical to Highlight Broad Portfolio of Innovative Medical Technologies at Boston Atrial Fibrillation Symposium.
St. Jude Medical Announces FDA Approval and U.S. Market Launch of the Merlin Patient Care System; New Programmer Brings 21st Century Advances to...
Clinical Trial Shows Device Optimizes Cardiac Resynchronization Therapy in Less Than Two Minutes; St. Jude Medical Announces QuickOpt Optimization...
Healthy start for hospital's fundraiser.
St. Jude Medical Announces FDA Approval and Launch of QuickOpt(TM) Timing Cycle Optimization for Heart Failure and ICD Patients; Innovative Feature...
St. Jude Medical Announces FDA Approval of New ICD Software for the Merlin(TM) Patient Care System.
TINSELTOWN SPYWITNESS.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles